United States · Series B startup

Who invested in Genome Insight

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Big Data & Analytics

Funding summaryUpdated 26 Oct 2026

$23Mraised across 1 round since 2023, from 1 source

Latest round
Series B, $23MNov 2023
Investors
3
See who backed them

The rounds

  1. Nov 2023

Everyone who backed them

DSC InvestmentVC firm1round
InterVest Co.VC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Genome Insight as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Paratus InvestmentPrivate equity2022, per its site

Quick answers about Genome Insight

Who invested in Genome Insight?

Genome Insight's investors include Samsung Venture Investment, DSC Investment and InterVest Co..

How much has Genome Insight raised?

Genome Insight has raised $23M across 1 round since 2023.

When did Genome Insight last raise?

Genome Insight's most recent round was a Series B of $23M in Nov 2023.

What was Genome Insight's biggest round?

Its most recent round, $23M in Nov 2023, is also its largest on record.

Who backed Genome Insight first?

Genome Insight's first round on record, in Nov 2023, was backed by Samsung Venture Investment, DSC Investment and InterVest Co..

What stage is Genome Insight at?

Genome Insight's latest named round is a Series B, in Nov 2023.

Where is Genome Insight based?

Genome Insight is based in the United States.

Companies like Genome Insight

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.